Appili Therapeutics and Colleagues Publish Manuscript on the Prevention and Emergency Response to Tularemia

  • A review of recent findings suggests that Appili's biodefense vaccine, ATI-1701, may have a role in preventing tularemia outbreaks A review of recent findings suggests that Appili's biodefense vaccine, ATI-1701, may have a role in preventing tularemia outbreaks